Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Machine learning-based identification of lower grade glioma stemness subtypes discriminates patient prognosis and drug response. Local targets link to admitted publications; unresolved targets remain external evidence.
Glioma
10.1038/nrdp.2015.17 · 2015 · External reference
10.1038/s41582-019-0220-2
10.1038/s41582-019-0220-2 · External reference
10.1038/nrclinonc.2016.204
10.1038/nrclinonc.2016.204 · External reference
10.1111/cns.13956
10.1111/cns.13956 · External reference
Glioma targeted therapy: insight into future of molecular approaches
10.1186/s12943-022-01513-z · 2022 · External reference
Recurrence- and malignant progression-associated biomarkers in low-grade gliomas and their roles in immunotherapy
10.3389/fimmu.2022.899710 · 2022 · External reference
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas
10.1056/nejmoa1402121 · 2015 · External reference
10.1016/j.cell.2018.03.034
10.1016/j.cell.2018.03.034 · External reference
Drug resistance driven by cancer stem cells and their niche
10.3390/ijms18122574 · 2017 · External reference
10.1148/radiol.2017151930
10.1148/radiol.2017151930 · External reference
10.1016/j.ccell.2020.04.001
10.1016/j.ccell.2020.04.001 · External reference
10.1038/s41392-021-00491-w
10.1038/s41392-021-00491-w · External reference
10.1126/science.1190929
10.1126/science.1190929 · External reference
10.1016/j.stem.2018.03.011
10.1016/j.stem.2018.03.011 · External reference
10.1007/s10072-018-3408-0
10.1007/s10072-018-3408-0 · External reference
10.1016/j.stemcr.2016.05.006
10.1016/j.stemcr.2016.05.006 · External reference
10.1038/s41587-020-0546-8
10.1038/s41587-020-0546-8 · External reference
10.1016/j.gpb.2020.10.005
10.1016/j.gpb.2020.10.005 · External reference
10.1186/gb-2011-12-4-r41
10.1186/gb-2011-12-4-r41 · External reference
10.1186/s13073-018-0567-9
10.1186/s13073-018-0567-9 · External reference
Exaggerated false positives by popular differential expression methods when analyzing human population samples
10.1186/s13059-022-02648-4 · 2022 · External reference
10.1093/nar/gkv1070
10.1093/nar/gkv1070 · External reference
10.1093/nar/gku1179
10.1093/nar/gku1179 · External reference
10.1089/omi.2011.0118
10.1089/omi.2011.0118 · External reference
GSVA: gene set variation analysis for microarray and RNA-seq data
10.1186/1471-2105-14-7 · 2013 · External reference
10.1016/j.cell.2019.05.031
10.1016/j.cell.2019.05.031 · External reference
10.1038/s41467-021-21407-w
10.1038/s41467-021-21407-w · External reference
Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritis
10.1186/s13073-022-01081-3 · 2022 · External reference
Single-cell RNA-Seq reveals the promoting role of ferroptosis tendency during lung adenocarcinoma EMT progression
10.3389/fcell.2021.822315 · 2021 · External reference
TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment
2021 · External reference
scCancer: a package for automated processing of single-cell RNA-seq data in cancer
2021 · External reference
10.1186/s13059-014-0550-8
10.1186/s13059-014-0550-8 · External reference
10.1016/j.csbj.2022.08.057
10.1016/j.csbj.2022.08.057 · External reference
10.1016/j.csbj.2022.09.037
10.1016/j.csbj.2022.09.037 · External reference
10.1016/j.csbj.2023.04.004
10.1016/j.csbj.2023.04.004 · External reference
10.1016/j.csbj.2022.12.036 · Admitted local publication
A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma
10.1038/s41388-021-01853-y · 2021 · External reference
Hypoxia-related lncRNA correlates with prognosis and immune microenvironment in lower-grade glioma
10.3389/fimmu.2021.731048 · 2021 · External reference
10.1038/s41591-018-0136-1
10.1038/s41591-018-0136-1 · External reference
10.1186/s13073-020-0721-z
10.1186/s13073-020-0721-z · External reference
10.1038/s43018-019-0018-6
10.1038/s43018-019-0018-6 · External reference
10.1038/ng.3984
10.1038/ng.3984 · External reference
oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data
10.1093/bib/bbab260 · 2021 · External reference
Multilevel models improve precision and speed of IC50 estimates
10.2217/pgs.16.15 · 2016 · External reference
10.1016/j.cell.2016.06.017
10.1016/j.cell.2016.06.017 · External reference
10.1038/nchembio.1986
10.1038/nchembio.1986 · External reference
10.1093/nar/gks1111
10.1093/nar/gks1111 · External reference
10.1016/j.canlet.2020.12.013
10.1016/j.canlet.2020.12.013 · External reference
10.1016/j.ccr.2009.12.020
10.1016/j.ccr.2009.12.020 · External reference
Reciprocal regulation of integrin β4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits
10.1186/s13046-019-1034-1 · 2019 · External reference
10.1093/neuonc/noaa249
10.1093/neuonc/noaa249 · External reference
Somatic mutations in ZFHX4 gene are associated with poor overall survival of Chinese esophageal squamous cell carcinoma patients
10.1038/s41598-017-04221-7 · 2017 · External reference
Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma
10.1172/jci147552 · 2021 · External reference
Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming
10.7150/thno.75069 · 2022 · External reference
An Arf/Rab cascade controls the growth and invasiveness of glioblastoma
10.1083/jcb.202004229 · 2021 · External reference
10.1101/2021.11.05.467405
10.1101/2021.11.05.467405 · External reference
Characterization of gastric cancer stem-like molecular features, immune and pharmacogenomic landscapes
2022 · External reference
Glioblastoma: microenvironment and niche concept
10.3390/cancers11010005 · 2018 · External reference
High levels of connexin 43 mRNA in high grade astrocytomas. Study of 32 cases with in situ hybridization
10.1016/j.acthis.2009.05.008 · 2010 · External reference
The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities
10.1093/neuonc/nov157 · 2016 · External reference
FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells
10.1016/j.canlet.2021.02.021 · 2021 · External reference
Single-cell RNA-sequencing shift in the interaction pattern between glioma stem cells and immune cells during tumorigenesis
10.3389/fimmu.2020.581209 · 2020 · External reference
Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia
10.1093/neuonc/noz080 · 2019 · External reference
10.1016/j.ccell.2019.05.003
10.1016/j.ccell.2019.05.003 · External reference
Single-cell transcriptomic analysis revealed a critical role of SPP1/CD44-mediated crosstalk between macrophages and cancer cells in glioma
10.3389/fcell.2021.779319 · 2021 · External reference
10.1038/s41467-021-23832-3
10.1038/s41467-021-23832-3 · External reference
10.1038/nm.4409
10.1038/nm.4409 · External reference
10.1089/scd.2007.0006
10.1089/scd.2007.0006 · External reference
10.1158/0008-5472.can-07-6878
10.1158/0008-5472.can-07-6878 · External reference
10.1093/neuonc/noab158
10.1093/neuonc/noab158 · External reference
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
10.1093/neuonc/nov011 · 2015 · External reference
Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice
10.1002/pros.22941 · 2015 · External reference
10.1073/pnas.1005642107
10.1073/pnas.1005642107 · External reference
10.3892/or.2017.5991
10.3892/or.2017.5991 · External reference
Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme
10.3171/2009.5.jns081738 · 2010 · External reference